{
  "ptid_time": "035_S_0033_2006-12-14",
  "img_path": "/data/qiuhui/data/adni/images/035_S_0033/2006-12-14/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 36,892 mm³, 21.5% below the reference mean. With a Z-score of -0.63 (26.6th percentile), this represents normal volume ; hippocampal volume measures 5,236 mm³, 24.9% below the reference mean. With a Z-score of -2.15 (1.6th percentile), this represents significant atrophy; whole brain volume measures 1,021,010 mm³, 0.8% below the reference mean. With a Z-score of -0.10 (45.9th percentile), this represents normal volume ; entorhinal cortex volume measures 2,622 mm³, 33.9% below the reference mean. With a Z-score of -2.22 (1.3th percentile), this represents significant atrophy; fusiform gyrus volume measures 17,409 mm³, 3.6% below the reference mean. With a Z-score of -0.31 (37.6th percentile), this represents normal volume ; middle temporal gyrus volume measures 17,851 mm³, 11.5% below the reference mean. With a Z-score of -1.03 (15.1th percentile), this represents mild atrophy. ",
  "text_data": "Age is 84.3 years. Gender is Male. Education: 20 years. MMSE: 28.0. Logical Memory: 0.0. APOEε4 alleles: 0.0. Biomarker levels: Amyloid beta: 643.20 pg/mL (mild reduced); Total tau: 338.60 pg/mL (mild elevated); Phosphorylated tau: 35.47 pg/mL (moderate elevated). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The patient shows significant atrophy in the hippocampus and entorhinal cortex (both below the 2nd percentile), which are key regions affected in Alzheimer's disease (AD). Mild atrophy in the middle temporal gyrus and biomarker findings (mildly reduced Aβ, elevated T-tau, and moderately elevated P-tau) further support AD pathology. However, the MMSE score of 28 is within the normal range, suggesting preserved cognitive function despite structural changes.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely due to Alzheimer's pathology)  \n**Confidence:** **Medium** (due to the discrepancy between significant atrophy/biomarkers and intact MMSE, though age and APOE4-negative status may influence progression rate).",
  "timestamp": "2025-07-26T05:42:00.658432"
}